Z-2256-2026 Class I Ongoing
FDA device recall Z-2256-2026 was initiated by Becton Dickinson & Company on Apr 27, 2026 and is designated Class I. Reason for recall: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA… The recall status is ongoing. Affected quantity: 0 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 10, 2026
- Initiation Date
- Apr 27, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 0 units
Product description
Reason for recall
Distribution pattern
Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, NE, NH, NJ, NV, NY, OH, OR, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV, WY.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2256-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Becton Dickinson & Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.